1832 Asset Management
MRTX

1832 Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

1832 Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-22,500
Closed -$2.36M – 771
2019
Q2 		$2.36M Buy
+22,500
New +$2.36M 0.01% 402